Metabolic engineering of Escherichia coli for shikimate pathway derivative production from glucose-xylose co-substrate.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31937786.
- Also identified by DOI 10.1038/s41467-019-14024-1 and PMC identifier 6959354.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Glucose and xylose are the major components of lignocellulose. Effective utilization of both sugars can improve the efficiency of bioproduction. Here, we report a method termed parallel metabolic pathway engineering (PMPE) for producing shikimate pathway derivatives from glucose-xylose co-substrate. In this method, we seek to use glucose mainly for target chemical production, and xylose for supplying essential metabolites for cell growth. Glycolysis and the pentose phosphate pathway are completely separated from the tricarboxylic acid (TCA) cycle. To recover cell growth, we introduce a xylose catabolic pathway that directly flows into the TCA cycle. As a result, we can produce 4.09 g L<sup>-1</sup> cis,cis-muconic acid using the PMPE Escherichia coli strain with high yield (0.31 g g<sup>-1</sup> of glucose) and produce L-tyrosine with 64% of the theoretical yield. The PMPE strategy can contribute to the development of clean processes for producing various valuable chemicals from lignocellulosic resources.
Medical subject headings
- Escherichia coli
- Glucose
- Shikimic Acid
- Xylose